Avai Bio (AVAI) Accounts Payables (2019 - 2023)
Avai Bio's Accounts Payables history spans 4 years, with the latest figure at $850000.0 for Q4 2023.
- For Q4 2023, Accounts Payables rose 877.0% year-over-year to $850000.0; the TTM value through Dec 2023 reached $850000.0, up 877.0%, while the annual FY2023 figure was $236901.0, N/A changed from the prior year.
- Accounts Payables for Q4 2023 was $850000.0 at Avai Bio, up from $138510.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.1 million in Q3 2020 and bottomed at $3800.0 in Q4 2019.
- The 4-year median for Accounts Payables is $70849.0 (2022), against an average of $221080.5.
- The largest annual shift saw Accounts Payables skyrocketed 11597.42% in 2020 before it surged 70.8% in 2023.
- A 4-year view of Accounts Payables shows it stood at $3800.0 in 2019, then surged by 11597.42% to $444502.0 in 2020, then tumbled by 80.43% to $87001.0 in 2022, then soared by 877.0% to $850000.0 in 2023.
- Per Business Quant, the three most recent readings for AVAI's Accounts Payables are $850000.0 (Q4 2023), $138510.0 (Q3 2023), and $121010.0 (Q2 2023).